Cameco, Canadian Utilities at 52-Week Highs on News
Cameco Corporation (T.CCO) hit a new 52-week high of $103.77 Thursday. Cameco today said its non-GAAP EPS of $0.71 beat estimates by $0.34, revenue of $877 Million beats by $288.71 Million.
Canadian Utilities Limited (T.CU) hit a new 52-week high of $38.36 Thursday. Canadian Utilities today announced second quarter 2025 adjusted earnings of $121 million ($0.45 per share), which were $4 million ( $0.02 per share) higher compared to $117 million ( $0.43 per share) in the second quarter of 2024.
ADYA Inc. (V.ADYA) hit a new 52-week high of 29.5 cents Thursday. No news stories today.
Agnico Eagle Mines Limited (T.AEM) hit a new 52-week high of $171.19 Thursday. No news stories today.
AltaGas Ltd. (T.ALA) hit a new 52-week high of $41.00 Thursday. No news stories today.
Badger Infrastructure Solutions Ltd. (T.BDGI) hit a new 52-week high of $41.00 Thursday. No news stories today.
Brookfield Renewable Corporation (T.BEPC) hit a new 52-week high of $50.55 Thursday. No news stories today.
Brookfield Corporation (T.BN) hit a new 52-week high of $93.16 Thursday. No news stories today.
BioNxt Solutions Inc. (C.BNXT) hit a new 52-week high of 69 cents Thursday. No news stories today.
Canaf Investments Inc. (V.CAF) hit a new 52-week high of 40 cents Thursday. No news stories today.
Clarke Inc. (T.CKI) hit a new 52-week high of $36.00 Thursday. No news stories today.
Coveo Solutions Inc. (T.CVO) hit a new 52-week high of $9.11 Thursday. No news stories today.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


